Jul. 23, 2014 8:56 pm
Question
Welcome!
|
||
Logout|My Dashboard

Merck warns docs to stop prescribing Tredaptive

Print
Font Size:
Default font size
Larger font size

Posted: Friday, January 11, 2013 9:12 am | Updated: 9:09 pm, Sun May 19, 2013.

Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive.

Merck told doctors to quit prescribing the medicine and advised patients to quit taking it only after talking to a physician.

The drug is not approved in the United States. Tredaptive is available in about 70 countries, including Europe.

Merck said last month initial results from a big, late-stage study showed that adding Tredaptive to traditional statin therapy did not lower the risk of heart attack, stroke and related problems. The drugmaker said then that doctors should stop prescribing Tredaptive to new patients.

Results also showed that patients taking the cholesterol combination pill were more likely to suffer some serious, non-fatal adverse events.

Merck says it made its decision based in part on a European Medicine Agency committee recommendation.

© 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy and Terms of Use.

Rules of Conduct

  • 1 Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
  • 2 Don't Threaten or Abuse. Threats of harming another person will not be tolerated. AND PLEASE TURN OFF CAPS LOCK.
  • 3 Be Truthful. Don't knowingly lie about anyone or anything.
  • 4 Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
  • 5 Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
  • 6 Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Welcome to the discussion.